1-naphthylamine has been researched along with Weight Gain in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bryant, SG; Fisher, S; Kent, TA | 1 |
| Hasert, M; Higley, J; Linnoila, M; Suomi, S | 1 |
| Chau, RY; Gunson, DE; Iverson, WO; McCormick, GM; Sahota, PS; Traina, VM | 1 |
1 trial(s) available for 1-naphthylamine and Weight Gain
| Article | Year |
|---|---|
The serotonin reuptake inhibitor sertraline reduces excessive alcohol consumption in nonhuman primates: effect of stress.
Topics: 1-Naphthylamine; Alcohol Drinking; Animals; Cross-Over Studies; Eating; Female; Hormones; Macaca mulatta; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress, Psychological; Time Factors; Weight Gain | 1998 |
2 other study(ies) available for 1-naphthylamine and Weight Gain
| Article | Year |
|---|---|
Postmarketing surveillance by patient self-monitoring: preliminary data for sertraline versus fluoxetine.
Topics: 1-Naphthylamine; Adult; Adverse Drug Reaction Reporting Systems; Aggression; Ambulatory Care; Confidence Intervals; Data Collection; Drug Monitoring; Female; Fluoxetine; Health Status; Humans; Male; Middle Aged; Patient Compliance; Probability; Product Surveillance, Postmarketing; Selective Serotonin Reuptake Inhibitors; Self Care; Sertraline; Telephone; Weight Gain | 1995 |
Toxic peripheral neuropathy with demyelination in Sprague-Dawley rats given CGS 21595--a 5-lipoxygenase inhibitor.
Topics: 1-Naphthylamine; Administration, Oral; Animals; Dose-Response Relationship, Drug; Female; Kidney Tubules, Proximal; Lipoxygenase Inhibitors; Male; Molecular Structure; Myelin Sheath; Prodrugs; Rats; Rats, Inbred Strains; Sciatic Nerve; Spinal Nerve Roots; Weight Gain | 1992 |